Last Updated: August 9, 2026

Details for Patent: 12,357,568

Name: Drug Patent Intelligence for US Patent 12357568
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 12,357,568 protect, and when does it expire?

Patent 12,357,568 protects TRIMBOW and is included in one NDA.

This patent has thirty-six patent family members in thirty-one countries.

Summary for Patent: 12,357,568

Title:	Aerosol formulation for COPD
Abstract:	Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions.
Inventor(s):	Sauro BONELLI, Francesca Usberti, Enrico Zambelli
Assignee:	Chiesi Farmaceutici SpA
Application Number:	US18/153,096
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Delivery; Device;
Patent landscape, scope, and claims:	error: insufficient information More… ↓ ⤷ Start Trial

Drugs Protected by US Patent 12,357,568

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chiesi	TRIMBOW	beclomethasone dipropionate; formoterol fumarate; glycopyrrolate	AEROSOL, METERED;INHALATION	219622-001	May 14, 2026		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			MAINTENANCE TREATMENT OF ASTHMA	⤷ Start Trial
Chiesi	TRIMBOW	beclomethasone dipropionate; formoterol fumarate; glycopyrrolate	AEROSOL, METERED;INHALATION	219622-002	May 14, 2026		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			MAINTENANCE TREATMENT OF ASTHMA	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 12,357,568

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010334858	⤷ Start Trial
Australia	2016234894	⤷ Start Trial
Brazil	112012015336	⤷ Start Trial
Canada	2785317	⤷ Start Trial
Chile	2012001668	⤷ Start Trial
China	102665680	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.